Gyanada Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2004.
2004 Mumbai, Maharashtra, India Amalgamated
Last Updated:
Access Report
About Gyanada Pharma Private Limited

Gyanada Pharma Private Limited, a amalgamated private limited company, was established on 30 September 2004 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24239MH2004PTC131058. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sindhu Seth (Director), Shiv Seth (Director). Past directors included Karn Seth, Varsha Vadera, Manu Darbari Seth. Its latest AGM occurred on 29 September 2014, with the balance sheet filed on 31 March 2014. It is based at 87 Jolly Maker Chamber No 28Th Floor K225 Jamnalal Baja J Marg Nariman Point, Mumbai, Maharashtra, 400021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH2004PTC131058

  • Registration Number

    131058

  • Incorporation Date

    30 September 2004

  • Authorized Capital

    ₹0.20 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Amalgamated

Key Metrics
  • Authorised Capital ₹ 0.20 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 21 Year, 4 Months
  • Last Filing with ROC 31 Mar 2014
Company report

Gyanada Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gyanada Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Gyanada Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sindhu Seth Director 30 Sep 2004 Current
Shiv Seth Director 15 Jul 2011 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Oct 2011 Past
Pramod Abcsdd Director 01 Aug 2014 Past
Pramod Abcsdd Director 24 Aug 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gyanada Pharma.

Enhance accessibility to Gyanada Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Gyanada Pharma revenue growth over time
Gyanada Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gyanada Pharma?

Unlock access to Gyanada Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Gyanada Pharma?

Unlock and access historical data on people associated with Gyanada Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gyanada Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gyanada Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gyanada Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Gyanada Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2014 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Gyanada Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Shiv Seth was appointed as a Director was appointed as a Director on 15 Jul 2011 & has been associated with this company since 14 years 6 months . was completed.

  • Director Appointment

    Sindhu Seth was appointed as a Director was appointed as a Director on 30 Sep 2004 & has been associated with this company since 21 years 4 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Gyanada Pharma Private Limited was registered on 30 Sep 2004 with Roc Mumbai & aged 21 years 4 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gyanada Pharma Private Limited?

The CIN of Gyanada Pharma Private Limited is U24239MH2004PTC131058.

Where is Gyanada Pharma Private Limited headquartered?

Gyanada Pharma Private Limited is headquartered at 87 Jolly Maker Chamber No 28Th Floor K225 Jamnalal Baja J Marg Nariman Point, Mumbai, Maharashtra, 400021.

When was Gyanada Pharma Private Limited incorporated?

Gyanada Pharma Private Limited was incorporated on 30 September 2004.

Who are the current directors of Gyanada Pharma Private Limited?

The current directors of Gyanada Pharma Private Limited are

What is the primary industry of Gyanada Pharma Private Limited?

The primary industry of Gyanada Pharma Private Limited is Chemicals.

Is Gyanada Pharma Private Limited a listed company?

Gyanada Pharma Private Limited is unlisted.

What is the capital structure of Gyanada Pharma Private Limited?

The authorized capital of Gyanada Pharma Private Limited is ₹0.20 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available